Category:

Health

Latest

India reports around 40 cases of Delta plus variant

“As of now among the samples sequenced (45000+) in India, Delta plus variant — AY.1 –has been observed sporadically in Maharashtra, Kerala and Madhya Pradesh, with around 40 cases identified so far and no significant increase in prevalence,” the ministry said in its statement.

These three states have been advised to strengthen surveillance and take appropriate public health measures.
 AstraZeneca Plc’s COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study.

The study by the Oxford University investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralize the Delta and Kappa variants, the statement said.

read more

Men took bigger jobs hit in pandemic across euro zone: ECB study

Men accounted for more than 60% of the jobs losses last year, while in terms of hours worked they suffered more than two-thirds of the overall drop, the ECB said in an Economic Bulletin article.

With women heavily represented in the leisure and hospitality sector, some economists and even ECB officials warned that women were at risk of losing more, but the study suggests that women found new work more easily then men.

read more

Delta variant ‘greatest threat’ to US’ COVID-19 efforts: Dr Fauci

”Similar to the situation in the UK, the Delta variant is currently the greatest threat in the US to our attempt to eliminate COVID-19,” Fauci told reporters during a virtual news conference here.

However, the “good news” is that the US vaccines are effective against the Delta variant, said Fauci, the head of the National Institutes of Allergy and Infectious Diseases (NIAID).

read more

Private hospitals to log 15-17% revenue growth in FY22: Crisil

“While the second wave lashed again in April, the first quarter this fiscal will be sharply better on-year, with occupancy of 75 per cent, almost double on-year. This will be largely on account of a surge in Covid-19 treatments more than offsetting the deferral of elective surgeries and outpatient footfalls,” Crisil Ratings Senior Director Manish Gupta said.

As the second wave recedes in the second quarter, Crisil expects pent-up demand for non-Covid treatments to rebound and support occupancy, he added.

read more